An Efficacy and Safety Study of LY3314814 in Early Alzheimer's Disease (AMARANTH)

  • sponsor
    Eli Lilly and Company
Updated on 8 December 2020


An Efficacy and Safety Study of LY3314814 in Early Alzheimer's Disease (AMARANTH)


SPRI is currently participating in a multi-center, 24-month clinical evaluation of an investigational drug for people suffering from mild cognitive impairment (MCI) or mild Alzheimer’s disease (AD).

Study medication and all study-related exams, tests, and procedures will be provided at no cost to you or your insurance company, with the exception of Namenda XR® or NamzaricTM.

Clinical Study IdentifierTX145335
SponsorEli Lilly and Company
Last Modified on8 December 2020


Yes No Not Sure

Inclusion Criteria

At a minimum, in order to be eligible in this clinical research study, you or someone you know must…
be between the ages of 50 and 85 years
been diagnosed with MCI or AD and
have a friend, family member or caregiver who has frequent contact with the participant
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note